Richard Bertz

Rick Bertz joined Biohaven Pharmaceuticals in 2019 as Vice President, Clinical Pharmacology and Pharmacometrics. Rick has worked in pharmaceutical industry for over 25 years, most recently as Vice President and Head, Clinical Pharmacology and Pharmacometrics at Bristol-Myers Squibb.

Rick has been involved in all phases of clinical drug development, with a focus on the analysis and interpretation of clinical pharmacology and pharmacometric data. He has mentored, coached, managed and developed numerous clinical pharmacologists and drug development scientists. Rick has been integrally involved in the completion of components of NDA submissions that have led to worldwide regulatory approval for several antiviral drugs for treatment of HIV and HCV.

Rick has coauthored over 75 peer-reviewed publications and given numerous invited presentations at national and international scientific meetings. He previously held a faculty appointment as Professor and Associate Dean at the University of Pittsburgh, School of Pharmacy, where he is currently an Adjunct Professor. Rick received a BS in Pharmacy from the University of Wisconsin and earned his PhD from the University of Pittsburgh Clinical Pharmaceutical Scientist Graduate Program.